Pancytopenia as the initial presenting feature in multiple myeloma: a case series
DOI:
https://doi.org/10.18203/2349-3933.ijam20231453Keywords:
Pancytopenia, Multiple myeloma, Initial presentationAbstract
Multiple myeloma is a plasma cell neoplasm characterized by abnormal proliferation of clonal cells in the bone marrow. Anaemia is generally the most common feature from hematologic aspect and bone pain being the other important symptom, but pancytopenia as the presenting feature is unusual. Here, we shared our experience of 3 cases with non-specific symptoms with pancytopenia which on through evaluation revealed our diagnosis. A hospital based observational descriptive case series was conducted wherein all the cases of multiple myeloma presenting with pancytopenia were included. Complete blood picture, peripheral smear, bone marrow aspirate and serum protein electrophoresis were reviewed and analysed. Pancytopenia as the initial presenting feature of multiple myeloma is an unique manifestation and diagnosing such cases require high degree of suspicion to avoid delay in the initiation of treatment.
References
Albagoush SA, Shumway C, Azevedo AM. Multiple Myeloma. Treasure Island (FL): StatPearls Publishing; 2022.
Hb S. Pancytopenia in multiple myeloma- an enigma: our experience from tertiary care hospital. J Clin Diagn Res. 2015;9.
Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97(8):1086-107.
Donk NWCJ, Pawlyn C, Yong KL. Multiple myeloma. Lancet. 2021;397(10272):410-27.
Pydi VR, Bala SC, Kuruva SP, Chennamaneni R, Konatam ML, Gundeti S. Multiple myeloma in young adults: a single centre real world experience. Indian J Hematol Blood Transfus Off J Indian Soc Hematol Blood Transfus. 2021;37(4):679-83.
Seesaghur A, Petruski-Ivleva N, Banks VL, Wang JR, Abbasi A, Neasham D, et al. Clinical features and diagnosis of multiple myeloma: a population-based cohort study in primary care. BMJ Open. 2021;11(10):052759.
Nau KC, Lewis WD. Multiple myeloma: diagnosis and treatment. Am Fam Physician. 2008;78(7):853-9.
Medhi K, Kalita D, Chopra A, Anand M, Raina V, Kumar R. Multiple myeloma presenting with coexisting severe marrow hypoplasia. Indian J Pathol Microbiol. 2008;51(4):543.
Ludwig H, Novis Durie S, Meckl A, Hinke A, Durie B. Multiple myeloma incidence and mortality around the globe; interrelations between health access and quality, economic resources, and patient empowerment. Oncologist. 2020;25(9):1406-13.
Sridevi HB, Rai S, Suresh PK, Somesh MS, Minal J. Pancytopenia in multiple myeloma- an enigma: our experience from tertiary care hospital. J Clin Diagn Res JCDR. 2015;9(11):4-6.
Chretien ML, Hebraud B, Cances-Lauwers V, Hulin C, Marit G, Leleu X, et al. Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients. Haematologica. 2014;99(7):1236-8.
Chiravuri S, De Jesus O. Pancytopenia. Treasure Island (FL): StatPearls Publishing; 2022.
Gayathri BN, Rao KS. Pancytopenia: a clinico hematological study. J Lab Physicians. 2011;3(1):15-20.
Chiravuri S, Jesus OD. Pancytopenia. Treasure Island (FL): StatPearls Publishing; 2022.
De Vriendt C. Severe pancytopenia as presenting feature in newly diagnosed multiple myeloma (NDMM): a rare presentation. UZ Gent. 2018.
Agarwal P, Nigam AS, Kumar V, Marwah S, Singh P. Plasmablastic light chain myeloma presenting as pancytopenia: An unusual presentation. Natl Med J India. 2017;30:266.
17. Al-Nujaidi D, Al-Shammasi S and Al-Anazi KA. Multiple Myeloma Presenting with Cytopenias. Austin Hematol. 2018;3(1):1018.
